Mitomycin is a medication used in the treatment of anal carcinoma, bladder carcinoma, breast carcinoma, head and neck malignancies, and some other gastrointestinal carcinomas. It is in the antineoplastic antibiotic class of medications. This activity reviews the mechanism of action, adverse event profile, indication, and contraindication for mitomycin as a valuable agent in managing gastrointestinal and urogenital cancers.

**Objectives:**
- Identify the mechanism of action of mitomycin.
- Describe the contraindications of mitomycin.
- Review the adverse effects/toxicity of mitomycin.
- Outline some interprofessional team strategies for improving care coordination and communication to advance mitomycin and improve outcomes.